Amaro Therapeutics
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7 Times Sq Fl 40, New York City, New Yor...Website
www.amarotx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Amaro Therapeutics
Amaro Therapeutics is focused on developing small-molecule agonists targeting extra-oral bitter taste receptors to address diseases related to metabolic dysfunction, chronic inflammation, and cellular senescence. Their innovative platform leverages over a decade of experience to identify and optimize these compounds, aiming to restore metabolic balance and regulate immune function. The company targets high-impact conditions such as obesity, type 2 diabetes, and metabolic-associated steatohepatitis (MASH) through a comprehensive approach that includes proprietary computational models and tissue-specific activation assays. Amaro Therapeutics is dedicated to creating a scalable pipeline of novel therapeutics that address the challenges of aging and metabolic diseases.Explore more
Amaro Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amaro Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Amaro Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Amaro Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Amaro Therapeutics
Funding: Get notified immidiatlly once Amaro Therapeutics has new funding data
Earning: See what the market has to say on Amaro Therapeutics recently announced quarterly report
Check if Amaro Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Amaro Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Amaro Therapeutics is spiking on competitors!
Recommended Actions
Find VP level buyers at Amaro Therapeutics
Find 3 more new buyers
Compare Similar Companies to Amaro Therapeutics
Compare insights from companies similar to Amaro Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
$81.2M
2008
MP
Marilena PerroneResearch & Development Operations Manager, Project Management
Company Profile Activity
Activity Insights
Amaro Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Amaro Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Amaro Therapeutics.
Amaro Therapeutics Tech Stack
A closer look at the technologies used by Amaro Therapeutics
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Amaro Therapeutics
Sign Up For FreeTo access detailed company insights
Amaro Therapeutics is focused on developing small-molecule agonists targeting extra-oral bitter taste receptors to address diseases related to metabolic dysfunction, chronic inflammation, and cellular senescence. Their innovative platform leverages over a decade of experience to identify and optimize these compounds, aiming to restore metabolic bal... Read More
